Successful treatment of FKBP51-expressed multicentric reticulohistiocytosis using combination therapy with low-dose denosumab and tacrolimus.

Mokuda, S; Oiwa, H

Mokuda, S; Oiwa, H.

Affiliation

Mokuda S; a Department of Rheumatology , Hiroshima City Hiroshima Citizens Hospital , Hiroshima , Japan.
Oiwa H; a Department of Rheumatology , Hiroshima City Hiroshima Citizens Hospital , Hiroshima , Japan.

Scand J Rheumatol ; 45(3): 247-9, 2016.

Article in En | MEDLINE | ID: mdl-26652057

Subject(s)

Arthritis/drug therapy; Bone Density Conservation Agents/therapeutic use; Denosumab/therapeutic use; Hand Joints/pathology; Histiocytosis, Non-Langerhans-Cell/drug therapy; Immunosuppressive Agents/therapeutic use; Tacrolimus/therapeutic use; Adult; Arthritis/diagnostic imaging; Arthritis/pathology; Drug Therapy, Combination; Female; Hand Joints/diagnostic imaging; Histiocytosis, Non-Langerhans-Cell/diagnostic imaging; Histiocytosis, Non-Langerhans-Cell/metabolism; Histiocytosis, Non-Langerhans-Cell/pathology; Humans; Radiography; Tacrolimus Binding Proteins/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Histiocytosis, Non-Langerhans-Cell / Tacrolimus / Hand Joints / Bone Density Conservation Agents / Denosumab / Immunosuppressive Agents Type of study: Diagnostic_studies Limits: Adult / Female / Humans Language: En Journal: Scand J Rheumatol Year: 2016 Document type: Article

Fulltext

XML

PubMed Links

Search on Google